Daniel A. Camardo
CIK 1820365 · CEO · last filed 2026-07-10
Daniel A. Camardo is a CEO who has filed 18 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for CUE, was dated Jul 10, 2026. Across all open-market trades the lifetime net is −$1.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $569.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$569.0K
3
18
-$1.21M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CUE | Director | 21,800 | $26.10 | $569.0K | $0 | 2 | 2026-07-10 |
| ATHERSYS, INC / NEW (ATHX) Delisted | CEO | 285,341 | $0.01 | $3.9K | $157.2K | 8 | 2023-10-06 |
| Horizon Therapeutics Public Ltd Co (HZNP) Delisted | EVP and President, U.S. | 51,181 | $116.30 | $5.95M | -$1.37M | 8 | 2021-04-05 |
Recent Filings
18 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-10 | CUE | Grant (A) | +21,800 | $0 | EDGAR |
| 2026-06-08 | CUE | Grant (A) | — | $0 | EDGAR |
| 2023-10-06 | ATHERSYS, INC / NEW (ATHX) Delisted | Tax (F) | −19,993 | -$8.8K | EDGAR |
| 2023-07-06 | ATHERSYS, INC / NEW (ATHX) Delisted | Tax (F) | −19,993 | -$18.3K | EDGAR |
| 2023-04-05 | ATHERSYS, INC / NEW (ATHX) Delisted | Tax (F) | −19,993 | -$20.0K | EDGAR |
| 2023-01-06 | ATHERSYS, INC / NEW (ATHX) Delisted | Tax (F) | −23,484 | -$20.0K | EDGAR |
| 2022-11-22 | ATHERSYS, INC / NEW (ATHX) Delisted | Buy (P) | +100,000 | $55.0K | EDGAR |
| 2022-10-06 | ATHERSYS, INC / NEW (ATHX) Delisted | Grant (A) | +263,492 | $0 | EDGAR |
| 2022-03-17 | ATHERSYS, INC / NEW (ATHX) Delisted | Buy (P) | +132,800 | $102.3K | EDGAR |
| 2022-02-14 | ATHERSYS, INC / NEW (ATHX) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.